To evaluate the effect of wtp53 function reactivation on cytotoxic lymphocyte-mediated lysis of cells harboring a mutated p53, we used CP-3139837 and the breast carcinoma cell line MDA-MB231. Here, TP53 is linked to breast carcinoma.